STOCK TITAN

Sonnet BioTherapeutics Holdings Inc - SONN STOCK NEWS

Welcome to our dedicated news page for Sonnet BioTherapeutics Holdings (Ticker: SONN), a resource for investors and traders seeking the latest updates and insights on Sonnet BioTherapeutics Holdings.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Sonnet BioTherapeutics Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Sonnet BioTherapeutics Holdings's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
66.38%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.78%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.15%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.58%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.04%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.34%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.45%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
25%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4%
Tags
none
Sonnet BioTherapeutics Holdings Inc

Nasdaq:SONN

SONN Rankings

SONN Stock Data

6.14M
2.71M
9.22%
3.53%
14.73%
Food Service Contractors
Accommodation and Food Services
Link
US
Princeton

About SONN

sonnet biotherapeutics is an early stage company developing a pipeline of bifunctional therapies that attack immune-modulating targets to control cancer cells. sonnet biotherapeutics is utilizing a platform approach to develop a library of cancer-fighting immunotherapies. sonnet is based in cranbury, new jersey. sonnet mission: sonnet biotherapeutics is a platform enabled proof-of-concept engine created to generate immuno-oncology candidates and develop them into phase ii assets. we are leveraging a unique ip driven platform: ● single chain platform with pk enhancement ● selectively targeting tumors and their micro-environment ● validated targets only ● dual targeting can create synergies